News

A glimpse at what to expect from Dermatology Times this week.

ICYMI, some of this week’s featured content includes the newest regulatory updates for cemiplimab for BCC and upadacitinib for PsA. Plus, stories on practice management, webinar recaps, and more.

In the second part of our 3-part recap series of our Roadmap to Recovery webinar, panelists discuss what aesthetic procedures dermatology practices can add to their existing list to increase profit and patient satisfaction.

In this month's Cosmetic Conundrums column, Dermatology Times® Chief Medical Editor Zoe Diana Draelos, MD, discusses allergies from skin care products and how to prevent adverse reactions.

This week’s edition of The Mainstream Patient features stories about face mapping, benzene contamination in sunscreen, natural retinol, ceramides in skin care, plus more.

In this month's Legal Eagle column, David J. Goldberg, MD, JD, dives into wrong-site surgeries and malpractice lawsuits.

In the first part of our 3-part recap series of our Roadmap to Recovery webinar, panelists discussed how the dermatology practice changed during COVID-19 and what changes they plan on keeping.

A study found WaterWipes, a baby wipe comprised of 99.9% water and a drop of fruit extract, helped reduce facial pressure injuries (FPI) caused by prolonged wear of personal protective equipment (PPE).

A glimpse at what to expect from Dermatology Times this week.

ICYMI, some of this week’s featured content includes a new podcast episode, as well as articles on treating skin conditions in Asian patients, the newest FDFA approvals, acne treatment updates from AAD, and more.

This week’s edition of The Mainstream Patient features stories about microcurrent facials, the psoriasis treatment journey, melanoma survivor stories, plus more.

Experts present detailed guidelines on how to diagnose and treat common skin diseases and conditions in the Asian American population.

Mallinckrodt announces the FDA approval of StrataGraft (allogeneic cultured keratinocytes and dermal fibroblasts in murine collagen – dsat) for the treatment of adults with thermal burns.

This episode dives into how health care policy impacts gender and sexual minority patients, including exploring the Affordable Care Act (ACA) and Medicaid expansion, and identifying state and federal nondiscrimination protections that help defend equal access to health care for this patient population.

Klint Peebles, MD, FAAD, co-chair of the AAD LGBTQ/GSM Expert Resource Group, tips and resources for maintaining your mental health as a gender and sexual minority.

A higher prevalence of vitamin D deficiency in people of color may be contributing to a higher burden of COVID-19 in minority populations. Dermatologists are encouraged to address vitamin D status in patients and recommend supplementation, which might have other health benefits.

The B-SIMPLE4 phase 3 trial achieved positive efficacy results for the treatment of molluscum contagiosum.

A glimpse at what to expect from Dermatology Times this week.

ICYMI, some of this week’s featured content includes new treatment guidelines for AK, health care impacts on gender and sexual minority patients, upadacitinib for atopic dermatitis, plus more

Join us in an upcoming webinar sponsored by Aerolase that provides the latest insight on how to grow your practice and profits beyond the COVID-19 pandemic.

This week’s edition of The Mainstream Patient features stories about microcurrent facials, the psoriasis treatment journey, melanoma survivor stories, plus more.

A glimpse at what to expect from Dermatology Times this week.

ICYMI, some of this week’s featured content includes how to provide the best care to your gender and sexual minority patients, updates in the pipeline for psoriasis, a new drug on the horizon for cSCC, plus more.

Each month, Dermatology Times® features a roundup of products trending in skin care. Click here to find out what products are trending for the month of June.

A glimpse at what to expect from Dermatology Times this week.

Christopher Bunick, MD, PhD, associate professor of dermatology, Yale University and Dermatology Times® editorial advisory board member, weighs in on a recent report revealing certain batches of various sunscreen and after-sun care products were contaminated with benzene, a carcinogen.

Despite the increase in availability, many patients still don’t know whether their physician offer telehealth.

A survey found that the pandemic boosted physician burnout and woke many up to their financial precarity.

This episode will highlight some breaking news coming out of the sun protection world with a report by Valisure, which found in a recent test that 78 different sunscreen and after-sun care products were contaminated with benzene, a potential carcinogen.

Nonprescription moisturizers and cleansers can play an integral role in delivering positive treatment outcomes for patients with rosacea.